Evodiamine inhibits RANKL‐induced osteoclastogenesis and prevents ovariectomy‐induced bone loss in mice

Postmenopausal osteoporosis (PMO) is a progressive bone disease characterized by the over‐production and activation of osteoclasts in elderly women. In our study, we investigated the anti‐osteoclastogenic effect of evodiamine (EVO) in vivo and in vitro, as well as the underlying mechanism. By using...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Cell Mol Med
Asıl Yazarlar: Jin, Haiming, Yao, Lingya, Chen, Kai, Liu, Yuhao, Wang, Qingqing, Wang, Ziyi, Liu, Qian, Cao, Zhen, Kenny, Jacob, Tickner, Jennifer, Wang, Xiangyang, Xu, Jiake
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6307789/
https://ncbi.nlm.nih.gov/pubmed/30451360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13955
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller